SCHEMBL5717004

SCHEMBL5717004

CC(C)(C)OC(=O)C1CCCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.59
HSD11B1 P28845 1/20 0.54
BRD4 O60885 2/20 0.52
HCRTR1 O43613 3/20 0.51
HCRTR2 O43614 3/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
KCNQ1 P51787 1/20 0.51
ALDH1A1 P00352 5/20 0.49
HTT P42858 2/20 0.49
BRD2 P25440 1/20 0.48
GAA P10253 1/20 0.47
MMP1 P03956 1/20 0.47
MMP3 P08254 1/20 0.47
MMP7 P09237 1/20 0.47
MMP13 P45452 1/20 0.47
FKBP1A P62942 1/20 0.47
EPHX2 P34913 1/20 0.46
KDM4E B2RXH2 1/20 0.46
AKR1C3 P42330 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717037 0.88 HCRTR1 (0.57) CASP3HSD11B1BRD4HCRTR1HCRTR2
SCHEMBL5717100 0.85 ALDH1A1 (0.64) BRD4HCRTR1HCRTR2MEN1KMT2A
SCHEMBL5717102 0.85 ALDH1A1 (0.64) BRD4HCRTR1HCRTR2MEN1KMT2A
SCHEMBL5717122 0.85 BRD4 (0.51) HSD11B1BRD4HCRTR1HCRTR2MEN1
SCHEMBL5717227 0.85 ALDH1A1 (0.64) BRD4HCRTR1HCRTR2MEN1KMT2A
SCHEMBL5717094 0.84 HCRTR1 (0.61) CASP3HSD11B1HCRTR1HCRTR2MEN1
SCHEMBL5717147 0.84 EPHX2 (0.52) CASP3HSD11B1HCRTR1HCRTR2MEN1
SCHEMBL5717146 0.84 EPHX2 (0.52) CASP3HSD11B1HCRTR1HCRTR2MEN1
SCHEMBL5716989 0.83 ALDH1A1 (0.66) HSD11B1BRD4HCRTR1HCRTR2MEN1
SCHEMBL5716988 0.83 ALDH1A1 (0.66) HSD11B1BRD4HCRTR1HCRTR2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664010-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS Vernalis (R&D) Limited (GB) 2006-06-07 EP disclosed
WO-2005068448-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS IONIX PHARMACEUTICALS LIMITED (GB) 2005-07-28 WO disclosed